Feldman, Al
14529  results:
Search for persons X
?
1

Oncology distress screening within predominately Black Vete..:

Azizoddin, D ; Allsop, M ; Farah, S...
https://eprints.whiterose.ac.uk/194928/8/Oncology%20distress%20screening%20within%20predominately%20Black%20Veterans%20Outcomes%20on%20supportive%20care%20utilization,%20hospitalizations,%20and%20mortality.pdf.  , 2023
 
?
2

Extranodal T- and NK-cell lymphomas:

de Leval, L ; Feldman, A.L ; Pileri, S..
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00428-022-03434-0.  , 2023
 
?
3

Using in-situ strain measurements to evaluate the accuracy ..:

Guglielmi Y ; McClure M ; Burghardt J...
info:eu-repo/semantics/altIdentifier/wos/WOS:001044036200001.  , 2023
 
?
5

The exponomial choice model for assortment optimization: an..:

Aouad, A ; Feldman, J ; Segev, D
https://lbsresearch.london.edu/id/eprint/2608/1/Aouad_MS_ExponomialChoice.pdf.  , 2023
 
?
6

Sensitivities of subgrid-scale physics schemes, meteorologi..:

Z. Xu ; E. R. Siirila-Woodburn ; A. M. Rhoades.
https://hess.copernicus.org/articles/27/1771/2023/hess-27-1771-2023.pdf.  , 2023
 
?
7

ESMO expert consensus statements on the management of EGFR ..:

Passaro, A ; Leighl, N ; Blackhall, F...
info:eu-repo/semantics/altIdentifier/pmid/35176458.  , 2022
 
?
8

Driving change in complex social systems : how to design he..:

Feldman, A ; Patou, F ; Maier, A
https://strathprints.strath.ac.uk/80961/1/Feldman_etal_DESIGN_2022_Driving_change_in_complex_social_systems_how_to_design_healthcare_pathways.pdf.  , 2022
 
?
11

Standards of Care for the Health of Transgender and Gender ..:

Coleman, E ; Radix, A. E ; Bouman, W. P...
Reproducció del document publicat a: https://doi.org/10.1080/26895269.2022.2100644.  , 2022
 
?
12

Driving Change in Complex Social Systems: How to Design Hea..:

Feldman, A ; Patou, F ; Maier, A
https://orbit.dtu.dk/en/publications/7fdd8903-cced-44f0-96d3-e35ca8e784a6.  , 2022
 
?
13

Standards of Care for the Health of Transgender and Gender ..:

Coleman, E ; Radix, A. E ; Bouman, W. P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553112/.  , 2022
 
?
14

ESMO expert consensus statements on the management of EGFR ..:

Passaro, A ; Leighl, N ; Blackhall, F...
Passaro , A , Leighl , N , Blackhall , F , Popat , S , Kerr , K , Ahn , M J , Arcila , M E , Arrieta , O , Planchard , D , de Marinis , F , Dingemans , A M , Dziadziuszko , R , Faivre-Finn , C , Feldman , J , Felip , E , Curigliano , G , Herbst , R , Jänne , P A , John , T , Mitsudomi , T , Mok , T , Normanno , N , Paz-Ares , L , Ramalingam , S , Sequist , L , Vansteenkiste , J , Wistuba , I I , Wolf , J , Wu , Y L , Yang , S R , Yang , J C H , Yatabe , Y , Pentheroudakis , G & Peters , S 2022 , ' ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer ' , Annals of Oncology , vol. 33 , no. 5 , pp. 466-487 . https://doi.org/10.1016/j.annonc.2022.02.003.  , 2022
 
1-15